Management

CHIEF EXECUTIVE OFFICER - AD VAN GORP, PHD

Ad van Gorp is a co-founder of Lead Pharma and has served as CEO since the inception of the company in 2007.

Prior to that, he was a member of the management team of Kiadis in Groningen, The Netherlands, where he was responsible for business development. Other previous positions include senior scientist at Numico research and Senior researcher at Unilever Research in Vlaardingen, The Netherlands, where he supervised the assay development and high throughput screening departments. Ad van Gorp had a fellow position at Janssen Pharmaceutica responsible for the development of cellular models for Alzheimer's disease.

Before starting his career in the pharmaceuticals industry, Ad van Gorp worked as a post-doc fellow in the Department of Human Genetics at the University of Leuven, Belgium, and as a post-doc fellow at the University of Amsterdam. He holds a degree in biology with specialization on biochemistry and molecular biology from Utrecht University and has obtained his PhD in cardiovascular physiology and pharmacology from the Cardiovascular Research Institute, University of Maastricht, The Netherlands, and Inserm Institute in Paris, France.

ยท      

CHIEF SCIENTIFIC OFFICER - ARTHUR OUBRIE, PHD

Arthur Oubrie was appointed as Chief Scientific Officer of Lead Pharma in July 2011. Together with Ad van Gorp, he is one of two legal executives of the company.

From 2005 to 2011, he worked as a research fellow at Organon, Schering Plough, and Merck. There he was, among others, leader or member of several lead identification and lead optimization teams, focusing on inflammatory and immunological indications. He also served as head of X-ray crystallography and structure-based drug design and chair of the global computational design working group. He actively contributed to the discovery and selection of various hits, leads, and a number of pre-clinical and clinical candidates and is co-inventor of several modulators of kinases and nuclear receptors.

From 2002 to 2005, Arthur Oubrie was lecturer (assistant professor) at the University of East Anglia in Norwich, UK, where he built a research group of eight scientists, all working on protein structure and function. Prior to that, he was a research fellow at the European Molecular Biology Laboratory in Heidelberg, Germany.

Arthur Oubrie holds a degree in chemistry from Radboud University in Nijmegen, The Netherlands, and a PhD in biophysical chemistry from the University of Groningen, The Netherlands.